Asthma treatment shortens Covid-19 recovery time
Researchers at Oxford University have discovered that an easily accessible asthma treatment can help speed up Covid-19 recovery times, by up to three days.
The treatment is inhaled budesonide, which is a common drug used in the treatment of asthma, and has been shown to reduce the recovery time from Covid-19 for those not hospitalized. While the UK has not recommended the treatment as a standard care procedure, it can now be prescribed to patients on a case by case basis.
The trial is so far the world’s largest randomized, controlled clinical trial (Phase III) to find a treatment that significantly shortened recovery time from the virus. What’s more, all of the participants who received the treatment and were not in the control group were over 65, or over 50 with an underlying health condition.
The drug is administered with two puffs a day for twenty eight days. A third of the patients taking the treatment recovered within two weeks at home, compared with less than a quarter of the patients who managed the same without the asthma drug.
The treatment group also reported better wellbeing after two weeks than those who followed usual care.
The drug prevents difficulty breathing, tightness of the chest, wheezing, and coughing that would be associated with asthma or Covid-19. This comes at a time when the current guidance for treating Covid-19 at home is very limited beyond over the counter medications for pain. Further results from the trial will be published at the end of the month.
Stay Up to Date on Clinical Trials
Citrus is a fully integrated recruitment and retention software that fits any clinical trial and simplifies the implementation of patient engagement in your clinical trial. Whether you are already working with CTMS systems or not, Citrus is the perfect add-on to make patient interaction effective.
Since 2015, our team has been hard at work raising awareness of clinical trials across the globe. A Forbes ‘30 Under 30’ company and a graduate of the renowned Techstar program in New York, Citruslabs is at the forefront of patient recruitment and retention technologies. With over 3 million patients now recorded on our databases, our patient recruitment dashboard is fast becoming the most efficient method of trial recruitment.
Now a #1 health app in 17 countries, our Mindmate app is helping to revolutionize the way we think about healthcare. Mindmate “[takes] senior care into the digital age” (Forbes, 2018) by providing people with the cognitive decline the essential tools to help them rebuild and maintain strong mental health. Trusted by millions of users, our health community continues to grow as the content available expands to the needs of individuals today.
With more than 200 research sites now using the Citrus platform to screen thousands of patients every month, researchers are now well on their way to finding new treatments for hundreds of different health conditions - something that just would not be possible without a technological solution. Make sure that your clinical trial is in the lucky 12% and turn that luck into guaranteed results with Citrus.
Check out what our customers have to say about us here.
And If you’d like to know more about how Citruslabs can help you recruit more effectively, get in touch with our team here.